Oct4 |
Forward |
5′-AGTGAGAGGCAACCTGGAGA-3′ |
52 |
Reverse |
5′-GTGAAGTGAGGGCTCCCATA-3′ |
Nanog |
Forward |
5′-TTCTTGACTGGGACCTTGTC-3′ |
52 |
Reverse |
5′-GCTTGCCTTGCTTTGAAGCA-3′ |
Sox2 |
Forward |
5′-GGGCAGCGTGTACTTATCCT-3′ |
52 |
Reverse |
5′-AGAACCCCAAGATGCACAAC-3′ |
HLA-G |
Forward |
5′-GCGGCTACTACAACCAGAGC-3′ |
58 |
Reverse |
5′-GCACATGGCACGTGTATCTC-3′ |
TERT |
Forward |
5′-GAGCTGACGTGGAAGATGAG-3′ |
55 |
Reverse |
5′-CTTCAAGTGCTGTCTGATTCCAATG-3′ |
Albumin |
Forward |
5′-TGAGTTTGCAGAAGTTTCCA-3′ |
60 |
Reverse |
5′-CCTTTGCCTCAGCATAGTTT-3′ |
TAT |
Forward |
5′-AACGATGTGGAGTTCACGG-3′ |
55 |
Reverse |
5′-GACACATCCTCAGGAGAATGG-3′ |
HNF1A |
Forward |
5′-TACACCACTCTGGCAGCCACACT-3′ |
60 |
Reverse |
5′-CGGTGGGTACATACCTGACAGAAC-3′ |
CYP2B6 |
Forward |
5′-CTTGACCTGCTGCTTCTTCC-3′ |
55 |
Reverse |
5′-TGCTTCCCGCCTCAGATTTCTC-3′ |
CYP3A4 |
Forward |
5′-ATCATTGCTGTCTCCAACCTTCAC-3′ |
60 |
Reverse |
5′-TGCTTCCCGCCTCAGATTTCTC-3′ |
β-actin |
Forward |
5′-TCCTTCTGCATCCTGTCAGCA-3′ |
58 |
Reverse |
5′-CAGGAGATGGCCACTGCCGCA-3′ |